Minimizing Facial Nerve Stimulation in Cochlear Implants

NCT ID: NCT04161261

Last Updated: 2021-07-29

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 24 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2019-12-13
• Study Completion Date: 2022-11-01

Brief Summary

This study aims to understand how to manipulate the electrical stimulation from the cochlear implant to maximize hearing stimulation and minimize facial stimulation. It is know from animal data that the hearing and facial nerves have different sensitivities to things like electrical pulse shape, its pattern, and its duration. It is very unclear however if this applies to human cochlear implant patients, and what the optimal parameters are to selectively stimulate the hearing nerve in humans. The outcomes of this study will be used to more selectively program some patients with severe facial nerve cross stimulation and to inform the development of new types of implant stimulation.

Detailed Description

The patients eligible for the study are deaf, and have consented as part of their standard of care to receiving a cochlear implant. There will be no interference with this process in any way. Those patients that are unfortunate to be affected by facial nerve stimulation following receiving their cochlear implant however will be contacted and with the aim to help improve their symptoms as indicated in prior animal studies

Conditions

Cochlear Hearing Loss; Hearing Loss, Sensorineural; Hearing Loss; Facial Nerve Injury; Nerve Disorders

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: SEQUENTIAL
• Primary Study Purpose: DIAGNOSTIC
• Blinding Strategy: NONE

Study Groups

IntraOperative Group

The intra-operative group consists of patients who have met criteria for cochlear implants. We monitor the facial nerve EMG intraoperatively in all patients, and often get some facial nerve activation when we are testing the implant intraoperatively when we are looking to see if we are getting any hearing nerve responses from electrical stimulation of the implant. We will also measure the facial nerve responses for some other charge-balanced pulse shapes, which are asymmetric and in which either the positive or negative charge is expected to stimulate the nerve. We will only measure these for two electrodes, not for all 12-22 electrodes They will be then invited back post operatively for a second testing during a standard of care visit post switch on for other pulse shapes.

Group Type: EXPERIMENTAL

Electrical Stimulation

Intervention Type: PROCEDURE

To measure the facial nerve stimulation threshold for one mid-array and one apical electrode of the implant using the pulse-train stimuli

PostOperative Group

The post-operative group, are patients who are actually having facial nerve stimulation on one or more electrodes, and for whom these electrodes are turned down so much they can't hear very well, or are actually turned off because of the facial nerve stimulation. For these patients, we will slowly increase the current levels on the offending electrodes (maximum of two) until they get some facial nerve twitching, and then turn down the current until they do not have stimulation any more. We will do this for all pulse shapes and determine which shape produces the greatest loudness without stimulating the facial nerve. This will be the only testing session for the second group.

Group Type: EXPERIMENTAL

Electrical Stimulation

Intervention Type: PROCEDURE

To measure the facial nerve stimulation threshold for one mid-array and one apical electrode of the implant using the pulse-train stimuli

Interventions

Electrical Stimulation

To measure the facial nerve stimulation threshold for one mid-array and one apical electrode of the implant using the pulse-train stimuli

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• Participant is willing and able to give informed consent for participation in the study.

• Male or Female, aged 18 years or above.
• Unilateral user of a cochlear implant or at least 6 months (post-operative group), or prospective CI user, meeting NICE criteria for implantation (intra-operative group).
• First language English or sufficiently fluent in English to understand the consenting process
• Post-lingual onset of severe to profound hearing loss
• No other handicaps that would interfere with participation in the study in the opinion of the Principal Investigator

Exclusion Criteria

• Unstable cochlear implant or hearing aid fitting

• Using medication in an intermittent manner that might influence hearing levels
• Cognitive or psychological challenges that might lead to variations in attention

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

University of Cambridge

OTHER

Sponsor Role: collaborator

Medical Research Council Cognition and Brain Sciences Unit

OTHER_GOV

Sponsor Role: collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

Sponsor Role: lead

Responsible Party

Sophie McKenny

/Chief Investigator Professor Manohar Bance

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Manohar L Bance, Professor

Role: PRINCIPAL_INVESTIGATOR

Cambridge University Hospitals NHS Foundation Trust

Locations

Addenbrookes Hospital

Cambridge, , United Kingdom

Countries

United Kingdom

Other Identifiers

272538

Identifier Type: -

Identifier Source: org_study_id